Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Profound Medical Inc. Appoints New CEO
Profound Medical Inc. (PMI) a company pioneering a unique, minimally invasive approach for the treatment of prostate cancer announced today... Read more
Functional Neuromodulation Inc. Closes Financing Agreements to Fund Phase II Testing for Potential Alzheimer's Treatment
October 17, 2011, Toronto, Ontario:  Functional Neuromodulation Inc, a company advancing deep brain stimulation (DBS) therapies for Alzheimer's Disease, today... Read more